NIH Annual Progress Report (RPPR) Review Plan. NIH RPPR and Final RPPR progress reports must be reviewed and approved by the Office of Sponsored Programs (OSP) prior to submission to NIH. Submission ...

This submission will be considered “late” and will not be eligible for OSP review or submission to NIH. “Ready-to-Submit" Proposals are due to OSP no later than 12:00 Noon the business day before the ...

NIH is hosting a free webinar regarding 2024 NIH Grants Policy Updates on Jan. 31 from 1 to 2:30 p.m. Register online for the webinar. Upon completion of this webinar, participants will be able to: ...

Texas Biomed has now received approval from the National Institutes of Health Office of Science Policy (NIH-OSP) to work with the attenuated virus in its biosafety level (BSL-2) laboratories.

NIH scientific integrity plan is fundamentally flawed, ... a spokesperson for the NIH Office of Science Policy. The NIH plans to publish the final policy in early 2024. ...

08/04/2023 By Holly Norton. Notice NOT-OD-23-161 updates the NIH application instructions for submitting requests for Data Management and Sharing costs in a single line item. As outlined in the Final ...

On May 22, 2024, the National Institutes of Health Office of Science Policy issued a Request for Information on its Draft NIH Intramural Research Program Policy: Promoting Equity Through Access ...

The Office of Research and Economic Development will host the virtual seminar NIH Program Officer, featuring Lyric Jorgenson, NIH acting director of the Office of Science Policy, from 12:30-2 p.m. Jan ...

Texas Biomed Professor Luis Martinez-Sobrido and his lab have received approval from NIH-OSP to work with a weakened version of SARS-CoV-2 in BSL-2 settings.

No articles found. NIH Office of Science Policy (OSP) did not contribute to any primary research papers from Nature Index journals in the current 12 month window ...

Texas Biomed has now received approval from the National Institutes of Health Office of Science Policy (NIH-OSP) to work with the attenuated virus in its biosafety level (BSL-2) laboratories.